Genetics of colorectal cancer (Review)

International Journal of Oncology

Volumn 9, Issue 2, 1996, Pages 327-335

  Peddanna, Narayanaswamy ^a   Mendis, Roger ^a   Holt, Stephen ^a   Verma, Ram S ^a,b  

^a SUNY DOWNSTATE MEDICAL CENTER   (United States)

^b LONG ISLAND COLLEGE HOSPITAL   (United States)

Author keywords

c myc oncogene; Colorectal adenoma; Colorectal cancer; Ki ras oncogene

Indexed keywords

CANCER GENETICS; CHROMOSOME 17Q; CHROMOSOME 18Q; CHROMOSOME 1P; CHROMOSOME 22Q; CHROMOSOME 5Q; CHROMOSOME 8P; COLON CARCINOGENESIS; COLORECTAL CANCER; GENE THERAPY; HETEROZYGOSITY; HUMAN; ONCOGENE C ERB; ONCOGENE C MYC; ONCOGENE K RAS; ONCOGENE SRC; PRIORITY JOURNAL; REVIEW; TUMOR SUPPRESSOR GENE;

EID: 0030057811     PISSN: 10196439     EISSN: None     Source Type: Journal    
DOI: 10.3892/ijo.9.2.327     Document Type: Review

References (122)

1. Armitage P and Doll R: The age distribution of cancer and a multistage theory of carcinogenesis. Br J Cancer 8: 1-13, 1954.
2. Harris AL: Mutant P53-the commonest genetic abnormality in human cancer. J Pathol 162: 5-6, 1990.
3. Astler VB and Coller FA: The prognostic significance of direct extension of carcinoma of the colon and rectum. Ann Surg 139: 846-852, 1954.
4. Symonds DA and Vickery AL: Mucinous carcinomas of the colon and rectum. Cancer 37: 1891-1900, 1976.
5. Woolam GL, Jackman RJ, Ramrex RJ, Beahrs OH and Dockery MB: Scirrhous carcinoma of lower intestine. Surg Gynecol Obstet 121: 753-755, 1965.
6. Atkinson BF, Ernst CS and Herlyn M: Gastrointestinal cancer associated antigen in immunoperoxidase assay. Cancer Res 42: 4820-4823, 1982.
7. Magnani JL, Nilson B and Brockhans M: A monoclonal antibody defined antigen associated with gastrointestinal cancer in ganglioside containing lacto-N-fucopentose 11. J Biol Chem 257: 14365-14369, 1982.
8. n. TAG 72 antigen in human colon cancer. Cancer Res 49: 197-204, 1989.
9. Fletcher RH: Carcinoembryonic antigen. Ann Intern Med 104: 66-70, 1986.
10. Boey J, Cheung HC and Lai CK: A prospective evaluation of serum Carcinoembryonic antigen levels in the management of colorectal carcinoma. World J Surgery 8: 279-284, 1984.
11. Northover JM: Carcinoembryonic antigen and recurrent colorectal cancer. Br J Surg 72: S44-S46, 1985.
12. Okawa S, Nakasato H and Kosaki G: Primary structure of human Carcinoembryonic antigen. Biochem Biophys Res Commun 142: 511-518, 1987.
13. Zotter S, Lossnitzer A and Hageman PC: Immunohistochemical localization of the epithelial marker MAM-6 in invasive malignancies and highly dysplastic adenomas of the large intestine. Lab Invest 57: 193-199, 1987.
14. Northover JMA and Murdy V: Familial colorectal cancer and familial adenomatous polyposis. In: Billierer's Clinical Gastroenterology. Bailliere (ed). Bailliere Indall, London, pp593-613, 1989.
15. Neel JV: Problems in the estimation of the frequency of uncommon inherited traits. Am J Hum Genet 6: 51-58, 1954.
16. Alm T and Diczneski G: The intestinal polyposis. Clin Gastroenterol 2: 577-601, 1973.
17. Jangelman DG: The expanding spectrum of familial adenomatous polyposis. Perspectives in colon. Rectal Surg 1: 30-46, 1988.
18. Bulow S: Familial polyposis coli. A clinical and epidemiological study. Dan Med Bull 34: 1-15, 1987.
19. Bussey HJR: Familial polyposis coli. Family Studies, Histopathology, Differential Diagnosis and Results of Treatment. John Hopkins University Press, Baltimore, 1975.
20. Gardner EJ: A genetic and clinical study of intestinal polyposis, a predisposing factor for carcinoma of colon and rectum. Am J Hum Genet 3: 167-176, 1951.
21. Blaire NP and Trempe CL: Hypertrophy of retinal epithelium associated with Garner syndrome. Am J Ophthalmol 90: 661-667, 1980.
22. Olschwang S, Tiret A, Laurent-Puig P, Muleris M, Parc R and Thomas G: Restriction of occular fundus lesions to a specific subgroup of APC mutations in adenomatous polyposis coli patients. Cell 75: 959-968, 1993.
23. Turcot J, Despres JP and St. Pierre T: Malignant tumors of central nervous system associated with familial polyposis of colon. Report of two cases. Dis Colon Rectum 2: 465-474, 1959.
24. Banghman FA, List CF, Williams JR, Muldon JP, Segarra JM and Volkel JS: The glioma-polyposis syndrome. N Engl J Med 281: 1345-1350, 1969.
25. Tops CM, Van der Klift HM and Van der Luijit RB: Non-allelic heterogeneity of familial adenomatous polyposis. Am J Med Genet 47: 563-567, 1993.
26. Mori T, Nagase H and Horii A: Germ-line and somatic mutations of the APC gene in patients with Turcot syndrome and analysis of APC mutations in brain tumors. Genes Chromosom Cancer 9: 168-172, 1994.
27. Jarvinen H, Nyberb M and Peltokallio P: Upper gastrointestinal tract polyps in familial adenomatous coli. Gut 24: 333-339, 1983.
28. Lynch HT and Lynch PM: Tumor variation in cancer family syndrome. Ovarian Cancer. Am J Surg 138: 439-442, 1979.
29. Lynch HT, Voorhees GJ and Lanspa SJ: Pancreatic carcinoma and hereditary non-polyposis colorectal cancer. A family study. Br J Cancer 52: 271-273, 1985.
30. Cristofaro G, Lynch HT and Carusso ML: New phenotypic aspects in a family with Lynch syndrome II. Cancer 60: 51-58, 1987.
31. Boman BM, Lynch H and Kimberiling WJ: Reassignment of cancer family syndrome gene to chromosome. Cancer Genet Cytogenet (In press).
32. Lynch HT, Kinberling WJ and Lynch JF: Hereditary nonpolyposis colorectal cancer (Lynch syndromes I and II) clinical description resource. Cancer 56: 934-938, 1985.
33. Mecklin JP: Frequency of hereditary colorectal carcinoma. Gastroenterology 98: 1021-1025, 1987.
34. Leach FS, Nicolaides NC and Papadopoulos N: Mutations of mutS homolog in hereditary nonpolyposis colorectal cancer. Cell 75: 1215-1225, 1993.
35. Fishel R, Lescoe MK and Rao MRS: The human imitator gene homolog MSH2 and its association with hereditary non-polyposis colon cancer. Cell 75: 1027-1038, 1993.
36. Liu B, Parsons RE and Hamilton SR: hMSH2 mutations in hereditary nonpolyposis colorectal cancer kindreds. Cancer Res 54: 4590-4594, 1994.
37. Peltomaki P, Lothe RA and Aalotonen LA: Microsatellite instability is associated with tumors that characterize the hereditary nonpolyposis colorectal carcinoma syndrome. Cancer Res 53: 5853-5855, 1993.
38. Papadopoulos N and Nicolaides NC: Wei mutation of mutL homolog in hereditary colon cancer. Science 263: 1625-1629, 1994.
39. Bronner CE, Baker SM and Morrison PT: Mutation in the DNA mismatch repair gene homologue hMLH1 is associated with hereditary nonpolyposis colon cancer. Nature 368: 258-261, 1994.
40. Nicolaides NC, Papadopoulos N and Liu B: Mutations of two PMS homologues in hereditary nonpolypsis colon cancer. Nature 371: 75-80, 1994.
41. Aaltonen LA, Peltomaki P, Leach FS, Sistonen P, Pylkkanen N and Mecklin JP: Clues to the pathogenesis of familial colorectal cancer. Science 260: 812-816, 1993.
42. Cannon-Albright LA, Skolnick MT, Bishop DT, Lee RG and Burt RW: Common inheritance of susceptibility to colonie adenomatous polyps and associated colorectal cancers. N Engl J Med 319: 553-537, 1988.
43. Grossman S and Milos ML: Colonoscopic screening of persons with suspected risk factors for colon cancer. I. Family history. Gastroenterology 39: 395-400, 1988.
44. Gryska PV and Cohen AN: Screening asymptomatic patients at high risk for colon cancer with full colonoscopy. Dis Colon Rectum 30: 18-20, 1987.
45. Guillem JG, Neugut AI, Forde KA, Waye JD and Treate MR: Colonie neoplasms in asymptomatic first-degree relatives of colon cancer patients. Amer J Gastroenterol 83: 271-273, 1988.
46. Guillem JG, Forde KA, Treate MR and Neugut AI: The colonoscopic detection of adenomas in asymptomatic first-degree relatives of colon cancer patients. A controlled, prospective study. Gastrointest Endoscop 35: 172-176, 1989.
47. McConell JC, Nizin JS and Slade MS: Colonoscopy in patients with a primary history of colon cancer. Dis Colon Rectum 33: 105-107, 1990.
48. Rozen P, Fireman Z, Figer A, Legum C, Ron E and Lynch HT: Family history of colorectal cancer as a marker of potential malignancy within screening program. Cancer 60: 248-254, 1987.
49. Bodmer WF, Bailey CJ, Bodmer J, Bussey HJR and Spur NK: Localization of the gene for familial adenomatous polyposis on chromosome 5. Nature 328: 614-616, 1987.
50. Herrera L, Kakate S, Gibas L and Sanberg A: Gardner syndrome in a man with interstitial deletion of 5q. Am J Med Genet 25: 473-476, 1986.
51. Leppert M, Sirambler P, Nakamura Y and White R: The gene for familial polyposis coli maps to the long arm of chromosome 5. Science 238: 1411-1413, 1987.
52. Meera Khan P, Tops CMJ, Van der Broek M, Brenkel C, Wijnen JT, Verspaget HM and Lamers CBHW: Close linkage of a highly polymorphic marker (D5S37) polyposis (FAP) and confirmation of FAP localization of chromosome 5q21-q22. Hum Genet 79: 183-185, 1988.
53. Leppert M, Burt R, Hughes JP, Nakamura Y and White R: Genetic analysis of an inherited predisposition to colon cancer in family with a variable number of adenomatous polyps. Lancet 335: 904-908, 1990.
54. Lynch HT, Kimbeling WJ, Albano WA and Lynch JF: Hereditary nonpolyposis colorectal cancer (Lynch syndromes I and II). Bio marker studies. Cancer 56: 939-951, 1985.
55. Willett W: The search for the causes of breast and colon cancer. Nature 338: 389-394, 1989.
56. Forrester K, Almoguera C, Han K, Grizzle WE and Perucho M: Detection of high incidence of K-ras oncogene during human colon tumorgenesis. Nature 327: 298-303, 1987.
57. Bos JL, Fearon SR, Hamilton M, Verlaan-Devries JH, Van Boom AJ, Vander EB and Vogelstein B: Prevalence of ras gene mutations in human colorectal cancers. Nature 327: 293-297, 1985.
58. Barbacid M: Ras genes. Annu Rev Biochem 56: 779-827, 1987.
59. McLellan EA, Owen RA, Stephieeswska KA, Sneffield JP and Lemoine NR: High frequency of k-ras mutations in sporadic colorectal adenomas. Gut 34: 392-396, 1993.
60. Bummer GC and Loeb LA: Mutations in k-ras oncogene during progressive stages of human colon carcinoma. Proc Natl Acad Sci USA 86: 2403-2407, 1989.
61. Vogelstein B, Fearon ER, Hamilton SR, Kern SE, Preisinger AC and Leppert M: Genetic alterations during colorectal cancer development. N Engl J Med 319: 525-532, 1988.
62. Miyoshi YH, Ando H, Nagase I, Nishisho A, Vogelstein B and Nakamura Y: Germ line mutations of the APC gene in 53 familial adenomatous polyposis patients. Proc Natl Acad Sci USA 89: 4452-4456, 1992.
63. Rothenberg PG, Spandorfer JM, Erisman MD, Starpscik RN, Sears HF and Peterson RO: Evidence that c-myc expression defines two genetically distinct form of colorectal adenocarcinoma. Br J Cancer 52: 629-632, 1985.
64. c-src protein kinase activity in human colon carcinoma. Proc Natl Acad Sci USA 84: 2251-2255, 1987.
65. c-src protein kinase is an early event in colonic carcinogenesis. Proc Natl Acad Sci USA 87: 558-562, 1990.
66. Studzinski GP, Brelvi ZS, Feldman SC and Watt RA: Participation of c-myc protein in DNA synthesis of human cells. Science 234: 467-469, 1986.
67. Meltzer SJ, Ahnen DJ, Battifora H, Yokota J and Cline MJ: Protooncogene abnormalities in colon cancers and adenomatous polyps. Gastroenterology 92: 1174-1180, 1987.
68. Sizeland AM and Burgess AW: Antisense transforming growth factor oligonucleotide inhibit autocrine stimulated proliferation of colon carcinoma cell line. Mol Biol Cell 3: 1235-1243, 1992.
69. Goelz SE, Vogelstein B, Hamilton SR and Feinberg AP: Hypomethylation of DNA from benign and malignant human colon neoplasms. Science 228: 187-190, 1985.
70. Schmid M, Haaf T and Grunert D: 5-azacytidine induced under condensations in human chromosomes. Hum Genet 67: 257-263, 1984.
71. DeMars R: Discussion 23rd annual symposium on fundamental cancer research. Williams and Wilkins, Baltimore, pp 105-106.
72. Knudson AG Jr: Genetics of human cancer. J Cell Physiol (Suppl) 4: 7-11, 1986.
73. Vogelstein B, Fearon ER, Kern SE, Hamilton SR, Preisinger Y and White R: Allelotype of colorectal carcinomas. Science 244: 207-211, 1989.
74. Vogelstein B, Fearon ER, Hamilton SR, Kern SE, Preisinger AC, Leppert M, Nakamura Y, White R and Bos JL: Genetic alterations during colorectal tumor development. N Engl J Med 319: 525-532, 1988.
75. Law DJ, Olschwang S, Monpetz JP, Lefrancois D, Jangleman D, Thomas G and Feinberg A: Concerted nonsystemic allelic loss in human colorectal carcinoma. Science 241: 961-965, 1988.
76. Rees M, Leigh SEA, Delhanty JDA and Jass JR: Chromosome 5 allele loss in familial and sporadic colorectal adenomas. Br J Cancer 59: 361-365, 1989.
77. Miyaki M, Seki M, Okamoto M, Yamanaka A, Maida Y, Tanaka K, Tonomura A, Nakamura Y, White R, Miki Y and Koike M: Genetic changes and histopathological types in colorectal tumors from patients with familial adenomatous polyposis. Cancer Res 50: 7166-7173, 1990.
78. Emi M, Fujiwara Y, Nakajima T, Tsuchiya E, Tsuda H, Herohashi S, Maeda Y, Tsuruta K, Miyaki M and Nakamura Y: Frequent loss of heterozygosity for loci on chromosome 8p in hepatocellular carcinoma, colorectal cancer, and lung cancer. Cancer Res 52: 5368-5372, 1992.
79. Leister I, Weithy A, Bruderelin S, Cziepluch C, Kangwanpong D, Schlag P and Schwab M: Human colorectal cancer. High frequency of deletions at chromosome 1p35. Cancer Res 50: 7232-7236, 1990.
80. Solomon E, Voss R, Hall V, Bodmer WF, Jefferys AJ, Lucibello FC, Patel I and Rider SH: Chromosome 5 allele loss in human colorectal carcinomas. Nature 328: 616-619, 1987.
81. Bodmer WF, Bailey CJ, Bodmer J, Bussey HJR, Ellis A, Gorman P, Lucibello FC, Murday VA, Rider SH, Scrambler P, Sheer D, Solomon E and Spurr NK: Localization of the gene for familial adenomatous polyposis on chromosome 5. Nature 328: 614-616, 1987.
82. Leppert MM, Dobbs P, Scrambler P, O'Conell Y, Nakamura Y, Stauffer S, Woodward R, Burt J, Hughes E, Gardner M, Lathrop J, Wasmuth JM and White R: The gene for familial polyposis coli maps to the long arm of chromosome 5. Science 238: 1211-1213, 1987.
83. Okamoto M, Sasaki M and Sugio K: Loss of constitutional heterozygosity in colon carcinoma from patients with familial polyposis coli. Nature 331: 273-277, 1988.
84. Powell SM, Zilz N, Beazer Barclay Y, Bryan JM, Hamilton SR, Thigodean SN, Vogelstein B and Kinzler KW: APC mutations occur early during colorectal tumorgenesis. Nature 359: 233-237, 1992.
85. Muser AR, Pitot HC and Dove WF: A dominant mutation that predisposes to multiple neoplasia in the mouse. Science 247: 322-324, 1990.
86. Su L, Kinzler KW and Vogelstein B: Multiple intestinal neoplasia caused by a mutation in the murine homolog of the APC gene. Science 256: 668-670, 1992.
87. Kinzler KW, Nilbert M and Vogelstein B: Identification of a gene located at chromosome 5q21 that is mutated in colorectal cancer. Science 251: 1366-1369, 1991.
88. Miki Y, Nishisho I and Miyoshi Y: Frequent loss of heterozygosity at the MCC locus on chromosome 5q21-22 in sporadic colorectal carcinomas. Jpn J Cancer Res 82: 1003-1007, 1991.
89. Bourne HR: Suppression with a difference. Nature 353: 696-698, 1991.
90. Fearon ER, Cho KR and Nigro JM: Identification of a chromosome 18q gene that is altered in colorectal cancer. Science 247: 49-56, 1990.
91. Yanoshita R, Konishi M, Fukunari H, Tanaka K and Miyaki M: Loss of expression of the DCC gene during progression of colorectal carcinomas in familial adenomatous polyposis and nonfamilial adenomatous polyposis patients. Cancer Res 52: 3801-3803, 1992.
92. Fearon ER and Vogelstein B: A genetic model for colorectal tumorgenesis. Cell 61: 759-767, 1990.
93. Pettomaki P, Sistonen P and Mecklin J: Evidence supporting exclusion of the DCC gene and a portion of chromosome 18q as the locus for susceptibility to hereditary non-polyposis colorectal carcinoma in five kindreds. Cancer Res 51: 4135-4140, 1991.
94. Nigro JM, Baker SJ, Preisinger AC and Vogelstein B: Mutations in the P53 gene may occur in diverse human tumor types. Nature 342: 705-708, 1989.
95. Baker SJ, Fearon ER, Nigro JM, Hamilton SR, Preisinger AC, Ledbetter DH, Barker DF, Nakamura Y, White R and Vogelstein B: Chromosome 17 deletions and P53 gene mutations in colorectal carcinomas. Science 244: 217-221, 1989.
96. Rodrigues N, Rowan A, Smith ME, Kerr IB, Bodmer WF, Cannon JV and Lane DP: P53 mutations in colorectal cancer. Proc Natl Acad Sci USA 87: 7555-7759, 1990.
97. Baker SJ and Preisinger AC: P53 gene mutations occur in combination with 17p allelic deletions as late events in colorectal tumorgenesis. Cancer Res 50: 7712-7717, 1990.
98. Lane M and Benchimol S: P53: oncogene or antioncogene? Gene Develop 4: 1-8, 1990.
99. Okamoto M, Saski M, Sugio K, Sato C, Iwama T, Tonomura A, Salazaki T and Miyaki M: Loss of constitutional heterozygosity on colon carcinoma from patients with familial polyposis coli. Nature 331: 273-277, 1988.
100. Delattre O, Law DJ, Remvikos Y, Saitre X, Feinberg AP, Olschway S, Salmor RJ and Thomas G: Multiple genetic alterations in distal and proximal colorectal cancer. Lancet 353: 353-356, 1989.
101. Vogel F: ABO blood groups and disease. Am J Hum Genet 22: 464, 1970.
102. Halvorsen TB: ABO blood groups, rhesus types and colorectal adenocarcinoma. A retrospective study of 747 cases. Scand J Gastroenterol 21: 979-983, 1980.
103. Slater G, Itzkowitz S and Arthur H: Clinicopathologic correlation of ABO and rhesus blood type in colorectal cancer. Dis Colon Rectum 36: 5-7, 1993.
104. Armitage NC, Robins RA, Evans BF, Baldwin RW and Hardcastle JD: The influence of tumor cell DNA abnormalities on survival in colorectal cancer. Br J Surg 72: 828-830, 1985.
105. Emidin SO, Sterling R and Roos G: Prognostic value of DNA content in colorectal cancer. A flow cytometric study of some methodologic aspects. Cancer 60: 1282-1287, 1987.
106. Kim YJ, Ngoi SS, Godwin TA, DeCosse JJ and Staino-Coico L: Ploidy in invasive colorectal cancer. Cancer 68: 638-641, 1991.
107. Neling GI, Rogrum TO, Chen Y, Lunde OC and Bergan A: Association between DNA ploidy pattern and cellular atypia in colorectal carcinomas. Cancer 67: 1642-1649, 1991.
108. Fischbach W, Zidianakis Z, Luke G, Kirchner T and Mossuer J: DNA mapping of colorectal neoplasms: a flow cytometric study of DNA abnormalities and proliferation. Gastroenterology 105: 1126-1133, 1993.
109. Van den Ingh H, Griffioen G and Comellise CJ: Flow cytometric detection of aneuploidy in colorectal adenomas. Cancer Res 45: 3392-3397, 1985.
110. Bardi G, Johansson B, Pandis N, Mandahl N, Bak-Jensen E, Lindstrom C, Tornqvist A, Frederidsen H, Mitelman F and Heim S: Cytogenetic analysis of 52 colorectal carcinomas-nonrandom aberration pattern and correlation with pathologic parameters. Int J Cancer 55: 422-428, 1993.
111. Johansson B, Heim S, Mandahl N, Mertens F and Mitelman F: Trisomy 7 in non-neoplastic cells. Genes Chromosom Cancer 6: 199-205, 1993.
112. Ferti AD, Panani AD and Raptis S: Cytogenetic study of rectosigmoidal adenocarcinomas. Cancer Genet Cytogenet 34: 101-109, 1988.
113. Muleris M, Salmon RJ and Dutrillaux B: Cytogenetics of colorectal adenocarcinomas. Cancer Genet Cytogenet 46: 143-156, 1990.
114. Bardi G, Johansson B, Pandis N, Orndal C, Mandl N and Mitelman F: Cytogenetic aberrations in colorectal adenocarcinomas and their correlation to clinicopathologic features. Cancer 71: 306-314, 1993.
115. Steig PS, Bevilacqua G and Kopper L: Evidence for a novel gene associated with low tumor metastatic potential. J Natl Cancer Inst 80: 200-204, 1988.
116. Sinicrope FA, Ruan SB, Cleary KR, Stephens C, Lee JJ and Levin B: bcl and P53 oncoprotein expression during colorectal tumorigenesis. Cancer Res 55: 237-241, 1995.
117. Laurent-Puig P: Les altérations genetiques du cancer du côlon et du rectum. Ann Pathol 14: 339-349, 1994.
118. Gioh H-S, Chan C-S, Khine K and Smith DR: P53 and behaviour of colorectal cancer. Lancet 344: 233-234, 1994.
119. Tempero M and Anderson J: Progress in colon cancer. Do molecular markers matter? N Engl J Med 331: 267-268, 1994.
120. Thomas G and Olschwang S: Genetic predispositions to colorectal cancer. Pathol Biol 43: 159-164, 1995.
121. Jen J, Kim H, Piantadosi S, et al: Allelic loss of chromosome 18q and prognosis in colorectal cancer. N Engl J Med 331: 213-221, 1994.
122. Cawkwell L and Quirke P: A new class of colorectal cancer gene. Gut 36: 641-643, 1995.